Search

everythinglearnresearchcommunity

for

Search:↓

NKIRAS2 can suppress certain skin tumors but its effect on cancer varies with context and expression level.

Tissue environment greatly affects the unique epigenetic makeup of regulatory T cells, which could impact autoimmune disease treatment.

Certain immune system proteins are important for skin healing but can cause problems if there are too many of them.

The document concludes that computational models are useful for understanding immune responses and could improve cancer immunotherapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Blocking LFA-1 prevents hair loss in mice.

Immune checkpoint inhibitors used in cancer therapy can cause hair loss, and understanding this can help manage the side effect.

CD8+ T cells drive alopecia areata, while regulatory T cells are protective.

RNase L hinders hair growth by altering immune signals.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

Blocking a certain signal in the gp130 receptor can improve tissue healing and lessen osteoarthritis symptoms.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

ILC1-like cells may contribute to hair loss in alopecia areata.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

ACKR2 helps prevent skin scarring and hair loss by controlling inflammation.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Ancient immune and signaling pathways still regulate blood cell development.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Proinflammatory fibroblasts and vascular endothelial cells are key in keloid development.

Early intervention with JAK inhibitors may prevent alopecia areata progression.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

Higher PD-1 levels mean fewer CD8+ T cells in alopecia areata hair follicles.

IL-1 signaling is crucial for hair follicle stem cell growth and wound healing.

Normal human melanocytes can avoid cell death through multiple pathways.

Immune therapy for cancer can cause rare hair loss but doesn't stop treatment success.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

The CD44-CD49d complex boosts T cell activation and survival in autoimmune disease.